| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |